re: marsbar Hey numbskull.
Recurring revenue some way off yes, but don't discount milestone payments due from Medtronic. I have a suspicion that cleverly when negotiations started over a year ago, XBL and Med merged the two technical teams so that if/when negotiations were completed they were already off to a running start on collaboration. So development is already basically a year ahead, and at each stage of development progress, XBL will get lumps of cash.
Not sure of background of ACU, but I like the look of it at the moment...
- Forums
- ASX - By Stock
- XBL
- is it time for biotechs?
XBL
xceed biotechnology ltd
is it time for biotechs?, page-8
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)